tiprankstipranks
Advertisement
Advertisement
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
PremiumThe FlyBest Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
3d ago
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
Premium
The Fly
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
3d ago
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
Premium
The Fly
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
4d ago
Morning Movers: Supernus and Indivior jump following merger pact
PremiumThe FlyMorning Movers: Supernus and Indivior jump following merger pact
5d ago
Video: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
Premium
The Fly
Video: Bristol Myers jumps, AstraZeneca sinks on report of tie-up talks
5d ago
AstraZeneca: Buy Rating Reaffirmed as Robust Pipeline and Strategic Optionality Drive Price Target Raise to $178
Premium
Ratings
AstraZeneca: Buy Rating Reaffirmed as Robust Pipeline and Strategic Optionality Drive Price Target Raise to $178
5d ago
AstraZeneca Falls, Bristol Myers Rises on Early Merger Talks for Potential $400B Deal
PremiumMarket NewsAstraZeneca Falls, Bristol Myers Rises on Early Merger Talks for Potential $400B Deal
5d ago
AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says
Premium
The Fly
AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says
5d ago
AstraZeneca, Daiichi Sankyo’s Datroway approved in EU
Premium
The Fly
AstraZeneca, Daiichi Sankyo’s Datroway approved in EU
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100